The Functional Topography of Transmembrane Domain 3 of the M1 Muscarinic Acetylcholine Receptor, Revealed by Scanning Mutagenesis*

Alanine-scanning mutagenesis has been applied to residues 100–121 in transmembrane domain 3 of the M1muscarinic acetylcholine receptor. This study complements a previous investigation of the triad Asp122-Arg123-Tyr124 (Lu, Z-L., Curtis, C. A., Jones, P. G., Pavia, J., and Hulme, E. C. (1997) Mol. Pharmacol. 51, 234–241). The results demonstrate the α-helical secondary structure of the domain and suggest its orientation with respect to the other transmembrane domains. The C-terminal part of the helix appears to be largely buried within the receptor structure. On its surface, there is a patch of three residues, Val113, Leu116, and Ser120, which may form intramolecular contacts that help to stabilize the inactive ground state of the receptor. Mutagenic disruption of these increased agonist affinity and signaling efficacy. In two cases (L116A and S120A), this led to constitutive activation of the receptor. Parallel to the helix axis and spanning the whole transmembrane region, a distinct strip of residues on one face of transmembrane domain 3 forms intermolecular (acetylcholine-receptor, receptor-G protein) or intrareceptor bonds that contribute to the activated state. The binding of acetylcholine may destabilize the first set of contacts while favoring the formation of the second.

[1]  A. Scheer,et al.  Constitutively active mutants of the alpha 1B‐adrenergic receptor: role of highly conserved polar amino acids in receptor activation. , 1996, The EMBO journal.

[2]  Jonathan A Javitch,et al.  Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method , 1995, Neuron.

[3]  H. Khorana,et al.  Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin: a site-directed spin labeling study. , 1995, Biochemistry.

[4]  T L Blundell,et al.  The evolution and structure of aminergic G protein-coupled receptors. , 1994, Receptors & channels.

[5]  C. Fraser,et al.  Site-directed mutagenesis of the rat m1 muscarinic acetylcholine receptor. Role of conserved cysteines in receptor function. , 1992, The Journal of biological chemistry.

[6]  E. Hulme,et al.  The role of the aspartate-arginine-tyrosine triad in the m1 muscarinic receptor: mutations of aspartate 122 and tyrosine 124 decrease receptor expression but do not abolish signaling. , 1997, Molecular pharmacology.

[7]  J. Wess,et al.  Site‐directed mutagenesis of the m3 muscarinic receptor: identification of a series of threonine and tyrosine residues involved in agonist but not antagonist binding. , 1991, The EMBO journal.

[8]  D. Oprian,et al.  Constitutively active mutants of rhodopsin , 1992, Neuron.

[9]  M. Brann,et al.  The Second Intracellular Loop of the m5 Muscarinic Receptor Is the Switch Which Enables G-protein Coupling* , 1998, The Journal of Biological Chemistry.

[10]  L. Birnbaumer,et al.  Differential expression of the beta-adrenergic receptor modifies agonist stimulation of adenylyl cyclase: a quantitative evaluation. , 1994, Molecular pharmacology.

[11]  O. Lichtarge,et al.  Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F , 1996, Nature.

[12]  J. W. Wells,et al.  Constitutive activation of the m5 muscarinic receptor by a series of mutations at the extracellular end of transmembrane 6. , 1997, Biochemistry.

[13]  S. Lazareno,et al.  Probing of the location of the allosteric site on m1 muscarinic receptors by site-directed mutagenesis. , 1995, Molecular pharmacology.

[14]  R. Lefkowitz,et al.  A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.

[15]  R. Lefkowitz,et al.  A ternary complex model explains the agonist-specific binding properties of the adenylate cyclase-coupled beta-adrenergic receptor. , 1980, The Journal of biological chemistry.

[16]  H. Khorana,et al.  Requirement of Rigid-Body Motion of Transmembrane Helices for Light Activation of Rhodopsin , 1996, Science.

[17]  J. Black,et al.  Operational models of pharmacological agonism , 1983, Proceedings of the Royal Society of London. Series B. Biological Sciences.

[18]  T. Clackson,et al.  A hot spot of binding energy in a hormone-receptor interface , 1995, Science.

[19]  E. Hulme,et al.  The function of a highly-conserved arginine residue in activation of the muscarinic M1 receptor. , 1995, European journal of pharmacology.

[20]  E. Hulme,et al.  Muscarinic acetylcholine receptors. Peptide sequencing identifies residues involved in antagonist binding and disulfide bond formation. , 1990, The Journal of biological chemistry.

[21]  E C Hulme,et al.  Acetylcholine mustard labels the binding site aspartate in muscarinic acetylcholine receptors. , 1994, The Journal of biological chemistry.

[22]  B. Kobilka,et al.  G Protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[23]  E. Hulme,et al.  Scanning mutagenesis of transmembrane domain 3 of the m1 muscarinic acetylcholine receptor , 1998, Journal of Physiology-Paris.

[24]  E. El-Fakahany,et al.  An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor. , 1994, Molecular pharmacology.

[25]  J. Baldwin,et al.  An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. , 1997, Journal of molecular biology.

[26]  A. Fersht,et al.  Protein engineering and the study of structure--function relationships in receptors. , 1990, Trends in pharmacological sciences.

[27]  D. Oprian,et al.  Constitutive activation of opsin: influence of charge at position 134 and size at position 296. , 1993, Biochemistry.

[28]  K. Page,et al.  The functional role of the binding site aspartate in muscarinic acetylcholine receptors, probed by site-directed mutagenesis. , 1995, European journal of pharmacology.

[29]  Robert P. Millar,et al.  Functional Microdomains in G-protein-coupled Receptors , 1998, The Journal of Biological Chemistry.

[30]  D. A. Dougherty,et al.  Cation-π Interactions in Chemistry and Biology: A New View of Benzene, Phe, Tyr, and Trp , 1996, Science.

[31]  J Hoflack,et al.  Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. , 1991, Molecular pharmacology.

[32]  K. Fahmy,et al.  Regulation of the rhodopsin-transducin interaction by a highly conserved carboxylic acid group. , 1993, Biochemistry.